2025 first_quarter Filing
Q1Income
$50K
Filed
April 21, 2025
Lobbying Activities
Medicare/MedicaidView all
General education about policies impacting pharmaceutical development, approval and reimbursement; Non-interference. Rebates for Medicare Part D. Importation. 340B Program. IPI drug pricing proposal, Medicare Rebate Rule. Drug pricing legislation, Medicare rebate reform, and proposals to impose "most favored nation" pricing on Medicare Part B and D. "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. H.R. 1492 and S. 832.
Contacted:HOUSE OF REPRESENTATIVES, SENATE
Budget/AppropriationsView all
Issues related to pharmaceutical development; Policies impacting Medicare Part D; Part B and 340 B programs.
Contacted:HOUSE OF REPRESENTATIVES, SENATE
Lobbyists (3)
SUSAN HIRSCHMANN
mr MATTHEW B HOEKSTRA
JEANNE HAGGERTY
Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member